1
|
van Schaik JE, van der Vegt B, van der Laan BF, Witjes MJ, Oosting SF, Fehrmann RS, Plaat BE. Abstract 6260: Identification of molecular imaging targets specific for head and neck squamous cell carcinoma by transcriptional adaptation to copy number alterations profiling: Digital data translated to protein expression. Cancer Res 2022. [DOI: 10.1158/1538-7445.am2022-6260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Objective: Head and neck squamous cell carcinoma (HNSCC) can intraoperatively be visualized by fluorescence molecular imaging (FMI) using fluorophores conjugated to HNSCC specific antibodies. Currently, the epidermal growth factor receptor (EGFR) is used as a target. Targets more specific for HNSCC would reduce background signal, resulting in a higher tumor to background ratio. We aimed to identify new potential targets for FMI in HNSCC.
Methods: Publicly available transcriptomic data were collected. A biostatistical method known as Transcriptional Adaptation to Copy Number Alterations (TACNA) profiling was applied, which captures the downstream effects of copy number alterations (CNAs) on mRNA levels, which we used to predict the overexpression on the protein level. By comparing gene expression profiles of HNSCC and normal oral mucosa, genes overexpressed explicitly in HNSCC were identified. Potential targets were selected based on the degree of overexpression, plasma membrane expression, and cross expression in other tissues in the head and neck region. Next, the expression of potential targets of TACNA results on mRNA level were validated on the protein level and compared to EGFR expression using immunohistochemistry (IHC). Subsequently, paired biopsies of HNSCC, adjacent suspicious mucosa, and healthy mucosa of the same patients were stained. Receptor expression was evaluated using H-scores (i.e., percentage of positive cells combined with staining intensity).
Results: TACNA profiling was applied on 111 samples of healthy oral mucosa and 410 HNSCC comparing expression levels of 19,635 genes. The newly identified membrane-bound targets were glucose transporter 1 (GLUT-1), placental cadherin (P-cadherin), and monocarboxylate transporter 1 (MCT-1). The three targets were evaluated by IHC in a total of 31 patients, of which 8 had oropharyngeal, 7 hypopharyngeal, and 16 laryngeal carcinomas. GLUT-1 had a median H-score of 175, P-cadherin 140, and MCT-1 40. GLUT-1 and P-cadherin were significantly higher compared to EGFR, with a median H-score of 90 (p < .001). GLUT-1 receptor expression was also seen on erythrocytes, while P-cadherin expression was seen in the basal layer of normal epithelium. This can complicate its use in FMI.
Conclusion: TACNA profiling results were successfully validated in immunohistochemistry as a first step in the search for new specific FMI targets in HNSCC. GLUT-1 and P-cadherin show promising results with significantly higher receptor expression than EGFR.
Citation Format: Jeroen E. van Schaik, Bert van der Vegt, Bernard F.A.M. van der Laan, Max J.H. Witjes, Sjoukje F. Oosting, Rudolf S. Fehrmann, Boudewijn E. Plaat. Identification of molecular imaging targets specific for head and neck squamous cell carcinoma by transcriptional adaptation to copy number alterations profiling: Digital data translated to protein expression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 6260.
Collapse
Affiliation(s)
| | | | | | - Max J.H. Witjes
- 1University Medical Center Groningen, Groningen, Netherlands
| | | | | | | |
Collapse
|
2
|
van Schaik JE, van der Vegt B, Hanemaaijer SH, Halmos GB, Witjes MJ, van der Laan BF, Fehrmann RS, Oosting SF, Plaat BE. Abstract 6261: Comparison of glycoprotein nonmetastatic melanoma protein b, epidermal growth factor receptor and vascular endothelial growth factor expression in head and neck squamous cell carcinoma, and untreated and residual lymph node metastases. Cancer Res 2022. [DOI: 10.1158/1538-7445.am2022-6261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Objective: To evaluate expression of the potential molecular imaging targets glycoprotein nonmetastatic melanoma protein B (GPNMB) and vascular endothelial growth factor (VEGF) in comparison to classical epidermal growth factor receptor (EGFR) in previously untreated head and neck cancer primary tumors and corresponding lymph node metastases, and in lymph node metastases after initial (chemo)radiotherapy. Methods: Primary tumors and lymph node metastases of 38 patients who underwent primary resection of head and neck squamous cell carcinoma (HNSCC) were selected. In addition, lymph node metastases from salvage surgery after (chemo)radiotherapy from 22 patients with HNSCC were selected. Immunohistochemical staining for EGFR, VEGF and GPNMB was performed, after which protein expression was scored using H-scores (percentage of positive tumor cells multiplied by staining intensity ranging from 0 to 2). Primary tumors and lymph node metastases with an H-score ≥5 were considered positive, after which sensitivity rates were calculated. Groups were compared using the Mann-Whitney U test for non-parametric data with post-hoc Bonferroni corrections. Results: In untreated primary HNSCC the sensitivity was 86.8% for EGFR (median H-score 60), 92.1% for VEGF (median 60), and 100% for GPNMB (median 100). In previously untreated lymph node metastases the sensitivity was 81.6% for EGFR (median 30), 86.8% for VEGF (median 65), and 100% for GPNMB (median 118). In lymph node metastases after initial (chemo)radiotherapy, sensitivity was 86.4% for EGFR (median 95) and 100% for GPMB (median 100). VEGF sensitivity could not reliably be evaluated in these lymph nodes due to nonspecific staining in all tissue slides. GPNMB expression was significantly higher compared to EGFR in untreated primary HNSCC (p = .009 and p < .001, respectively) and lymph node metastases (p < .001 for both). Conclusion: GPNMB shows better tumor-specific receptor expression in both sensitivity and H-scores compared to EGFR and VEGF in immunohistochemistry. VEGF performed comparable to EGFR in untreated HNSCC and lymph node metastases. GPNMB could therefore be a new potential imaging target based on these immunohistochemical results.
Citation Format: Jeroen E. van Schaik, Bert van der Vegt, Saskia H. Hanemaaijer, Gyorgy B. Halmos, Max J. Witjes, Bernard F.A.M. van der Laan, Rudolf S. Fehrmann, Sjoukje F. Oosting, Boudewijn E. Plaat. Comparison of glycoprotein nonmetastatic melanoma protein b, epidermal growth factor receptor and vascular endothelial growth factor expression in head and neck squamous cell carcinoma, and untreated and residual lymph node metastases [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 6261.
Collapse
Affiliation(s)
| | | | | | | | - Max J. Witjes
- 1University Medical Center Groningen, Groningen, Netherlands
| | | | | | | | | |
Collapse
|
3
|
de Vries J, Heirman AN, Bras L, Plaat BE, Rácz E, van Kester MS, Festen S, de Bock GH, van der Laan BF, Halmos GB. Geriatric assessment of patients treated for cutaneous head and neck malignancies in a tertiary referral center: Predictors of postoperative complications. Eur J Surg Oncol 2020; 46:123-130. [DOI: 10.1016/j.ejso.2019.08.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Revised: 08/09/2019] [Accepted: 08/09/2019] [Indexed: 12/20/2022] Open
|
4
|
Jager-Wittenaar H, Dijkstra PU, Dijkstra G, Bijzet J, Langendijk JA, van der Laan BF, Roodenburg JL. High prevalence of cachexia in newly diagnosed head and neck cancer patients: An exploratory study. Nutrition 2017; 35:114-118. [DOI: 10.1016/j.nut.2016.11.008] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2016] [Revised: 11/06/2016] [Accepted: 11/29/2016] [Indexed: 01/10/2023]
|
5
|
Jager-Wittenaar H, Dijkstra PU, Earthman CP, Krijnen WP, Langendijk JA, van der Laan BF, Pruim J, Roodenburg JL. Validity of bioelectrical impedance analysis to assess fat-free mass in patients with head and neck cancer: An exploratory study. Head Neck 2014; 36:585-91. [DOI: 10.1002/hed.23336] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2012] [Revised: 01/16/2013] [Accepted: 04/04/2013] [Indexed: 11/06/2022] Open
Affiliation(s)
- Harriët Jager-Wittenaar
- Department of Oral and Maxillofacial Surgery; University of Groningen, University Medical Center Groningen; Groningen The Netherlands
- Hanze University of Applied Sciences; Professorship in Health Care and Nursing; Groningen The Netherlands
| | - Pieter U. Dijkstra
- Department of Oral and Maxillofacial Surgery; University of Groningen, University Medical Center Groningen; Groningen The Netherlands
- Department of Rehabilitation; University of Groningen, University Medical Center Groningen; Groningen The Netherlands
| | - Carrie P. Earthman
- University of Minnesota; Department of Food Science and Nutrition, College of Food, Agricultural and Natural Resource Sciences; St. Paul MN
| | - Wim P. Krijnen
- Hanze University of Applied Sciences; Professorship in Health Care and Nursing; Groningen The Netherlands
| | - Johannes A. Langendijk
- Department of Radiation Oncology; University of Groningen, University Medical Center Groningen; Groningen The Netherlands
| | - Bernard F.A.M. van der Laan
- Department of Otorhinolaryngology/Head and Neck Surgery; University of Groningen, University Medical Center Groningen; Groningen The Netherlands
| | - Jan Pruim
- Department of Nuclear Medicine and Molecular Imaging; University of Groningen, University Medical Center Groningen; Groningen The Netherlands
| | - Jan L.N. Roodenburg
- Department of Oral and Maxillofacial Surgery; University of Groningen, University Medical Center Groningen; Groningen The Netherlands
| |
Collapse
|
6
|
Grainger DW, van der Mei HC, Jutte PC, van den Dungen JJ, Schultz MJ, van der Laan BF, Zaat SA, Busscher HJ. Critical factors in the translation of improved antimicrobial strategies for medical implants and devices. Biomaterials 2013; 34:9237-43. [DOI: 10.1016/j.biomaterials.2013.08.043] [Citation(s) in RCA: 74] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2013] [Accepted: 08/17/2013] [Indexed: 11/27/2022]
|
7
|
Peters TT, Langendijk JA, Plaat BE, Wedman J, Roodenburg JL, van Dijk BA, Sluiter WJ, van der Laan BF, Halmos GB. Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: A matched control study. Oral Oncol 2011; 47:1159-64. [DOI: 10.1016/j.oraloncology.2011.08.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2011] [Accepted: 08/03/2011] [Indexed: 11/25/2022]
|
8
|
Harms K, Post WJ, van de Laan KT, van den Hoogen FJ, Eerenstein SE, van der Laan BF. A prospective randomized multicenter clinical trial of the Provox2 and Groningen Ultra Low Resistance voice prostheses in the rehabilitation of post-laryngectomy patients: A lifetime and preference study. Oral Oncol 2011; 47:895-9. [DOI: 10.1016/j.oraloncology.2011.04.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2011] [Accepted: 04/13/2011] [Indexed: 10/18/2022]
|
9
|
Beetz I, Burlage FR, Bijl HP, Hoegen-Chouvalova O, Christianen ME, Vissink A, van der Laan BF, de Bock GH, Langendijk JA. The Groningen Radiotherapy-Induced Xerostomia questionnaire: Development and validation of a new questionnaire. Radiother Oncol 2010; 97:127-31. [PMID: 20541272 DOI: 10.1016/j.radonc.2010.05.004] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2010] [Revised: 05/15/2010] [Accepted: 05/15/2010] [Indexed: 10/19/2022]
|
10
|
Krabbe CA, Pruim J, van der Laan BF, Rödiger L, Roodenburg JL. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: A comparison with chest radiography and chest CT. Oral Oncol 2009; 45:234-40. [DOI: 10.1016/j.oraloncology.2008.05.024] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2008] [Revised: 05/29/2008] [Accepted: 05/30/2008] [Indexed: 11/25/2022]
|